In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1855 News Items found
Man in his 70s (prostate cancer patient) smiling for camera
FDA Expands New Treatment for Metastatic Prostate Cancer: Targets a Protein Called PSMA

Learn more about a new radiopharmaceutical treatment for prostate cancer approved by the FDA for more patients.
A researcher working in an MSK lab
MSK Research Highlights, May 19, 2025

New MSK research uncovers new details of the immune response against leptomeningeal metastasis; develops a grading system to assess the risk of developing thrombocytopenia after CAR T cell therapy; and outlines a method for scientists to estimate metabolic characteristics from challenging clinical samples.
GSK Graduates and MSK Leadership pose on the stage
MSK’s 2025 Convocation Inspires and Honors Achievement

At Memorial Sloan Kettering Cancer Center’s 46th annual ceremony, graduating master's and PhD students were honored and award winners were recognized.
Chrysothemis Brown
MSK Researchers Identify Key Player in Childhood Food Allergies: Thetis Cells

Thetis cells, a class of immune cells first described by MSK researchers in 2022, play an essential and previously unknown role in suppressing inflammatory responses to food, a new study finds.
Dr. Rachel Grisham
FDA Approves Avutometinib-Defactinib Combination for Treating Recurrent Low-Grade Serous Ovarian Cancer With a KRAS Mutation

The FDA has approved the first-ever treatment developed for low-grade serous ovarian cancer, a rare type of ovarian cancer.
A lab coat with an MSK logo hangs on a hook
Meet the 2025 Graduates of the Gerstner Sloan Kettering Graduate School

Fourteen young scientists are poised to receive their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. Their years of dedication and training will be recognized on May 14, 2025, as part of Memorial Sloan Kettering’s 46th annual academic convocation.
Patient Jason Weiner and his family
Promising New Treatment for Myelofibrosis Blood Cancer Using a Combination Targeted Therapy 

A phase 3 trial for myelofibrosis found that adding pelabresib to ruxolitinib was more effective than ruxolitinib alone and did not significantly increase side effects.
Jung Hun Oh
Pregnancy-Related Proteins in Tumors Linked to Worse Survival in Female Lung Cancer Patients

Lung cancer co-opts genes that normally help a fetus develop and evade the mother’s immune system — leading to poorer outcomes in female patients, an MSK research team has found.
Man posing with his wife, son, and daughter.
Clinical Update
Immunotherapy After Surgery Helps Prevent Cancer Recurrence in MMRd Patients With ctDNA, MSK Study Shows

Read about clinical trial results showing that a liquid biopsy helped select cancer patients for effective immunotherapy treatment.
David and Margaret
Potential New Treatment for KRAS-GI2D Lung Cancer Reported in First-of-Its-Kind Clinical Trial

For the first time, a targeted drug is showing promise at treating non-small cell lung cancer caused by a mutation called KRAS-G12D.